ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill
- Conditions
- Critically Ill Patients
- Interventions
- Procedure: Observational
- Registration Number
- NCT01317381
- Lead Sponsor
- University of Zurich
- Brief Summary
ICG- Leberfunktionstest versus "neue" Biomarker als prognostischer Marker bei intensivmedizischen Patienten
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ICU patients Observational Admitted patients to the ICU
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method